AMCP’s Post

For decades, health plans and PBMs railed against drug company pricing and margins. Now, the latest verticalization move in the industry has them buying down (or is it up?) the food chain. If you can't beat 'em, join 'em? Looking forward to see who moves next.   https://lnkd.in/gKuhWSrf   #PBM #DrugBenefits #Pharmacy #ManagedCarePharmacy #Formulary #HealthPlans #Biosimilars #Pharma #HealthCareBusiness #5ForcesofHCT #HCTVerticalization

In her latest article, Elena Meurer dives deep into the complexities of manufacturing targeted medicines on a global scale 🌍 Discover how companies navigate diverse regulatory frameworks, ensure product quality, and manage the intricate balance between customization and standardization. Read more to explore the strategies and insights that can help manufacturers overcome these challenges and deliver maximum benefit to patients. 🔗 https://lnkd.in/dmfd4P8R #Pharma #TargetedMedicines #Healthcare #RegulatoryAffairs #QualityControl #PharmaLex

On 19 April, the Health Resources and Services Administration published a final rule in the Federal Register adopting several changes to the current administrative dispute resolution process under the 340B Drug Pricing Program. Read our insights here. https://lnkd.in/eaXjmTmu #health #pharma #drugpricing

In her latest article, Elena Meurer dives deep into the complexities of manufacturing targeted medicines on a global scale 🌍 Discover how companies navigate diverse regulatory frameworks, ensure product quality, and manage the intricate balance between customization and standardization. Read more to explore the strategies and insights that can help manufacturers overcome these challenges and deliver maximum benefit to patients. 🔗 https://lnkd.in/g4J3bM7w #Pharma #TargetedMedicines #Healthcare #RegulatoryAffairs #QualityControl #PharmaLex

See our latest blog on the impact of biosimilars on the Humira drug market. Discover how these alternatives are driving down costs for patients and clients, making health care more affordable and accessible. Read it here: https://bit.ly/3Rh3L4E #Pharmacy #HealthCare

NEW BLOG POST: Navigating the Impact of Drug Recalls on Public Health: A Comprehensive Examination In the ever-evolving landscape of pharmaceuticals, drug recalls represent a critical crisis where patient safety and the intricate dance between therapeutic benefits and potential risks meet. Recent years have witnessed a surge in drug recalls, prompting extensive discussions about their profound impact on public health. To read the entry, please visit: https://lnkd.in/ds8BbN6F #medicationadherence #medical #fda #medication #medicationmanagement #recalls

Why is gaining specialty network access so challenging? Payor expert John Luebker has the answers and advice you need to be successful: https://lnkd.in/eXZfiVkK #pharmacy #pharma #healthcare #blog #healthinsurance

Is your New Year's resolution all about improving your hospital's drug spending? This video's for you: https://lnkd.in/etSVxhbi 🔗 Hear how one health system says CPS Optimizer has helped their pharmacy reduce drug costs to just $20 PPD. See how they did it: 📹 https://lnkd.in/etSVxhbi #pharmacy #specialtypharmacy #CPSOptimizer #hospitalpharmacy #clinicalpharmacy

This week marked 40 years since the generic medicines industry was empowered by Hatch-Waxman. The competition provided by this law was a success as over 90% of all prescriptions dispensed today are generics or biosimilars, yet combined they only make up 13 percent of total drug spending. #Generics and #biosimilars have saved America's patients and the U.S. healthcare system over $3 trillion in just the last 10 years. But over time, Hatch-Waxman has been chipped away. Now, more than ever, we need swift action from our regulators and legislators to protect patient access to lower-cost drugs for the next 40 years and beyond. MORE: https://lnkd.in/d9dGQVRi Biosimilars Council

Drug #recalls taking too much time from your #pharmacy team? Join our webinar and learn how to: 🔎 Identify recalled product faster 💊 Speed up retrieval of recalled product 💸 Accelerate reimbursement Register today: https://bit.ly/3TXtiBa